Navigation Links
Croissance Clinical Research Collaborates with Acceliant for Clinical Trial Excellence
Date:1/8/2014

BANGALORE, India, January 8, 2014 /PRNewswire/ --

Acceliant, a global technology provider of innovative clinical trial data management solutions, stated that Croissance Clinical Research, a full-fledged CRO providing services for pharmaceutical, bio-technology and medical devices companies, has preferred to choose Acceliant's eClinical Suite to aid their clinical trial data management. Acceliant's integrated e-PRO/EDC system offers a superior solution by allowing complete study data to be readily available and eliminating the integration costs.

     (Logo: http://photos.prnewswire.com/prnh/20130627/625230)

Satish Marukurthi, CEO, Croissance Clinical Research, said on this partnership, "Acceliant is our partner of choice based on their proven track record of accomplishments and expertise. We evaluated Acceliant eClinical Suite as being superior to other products in terms of driving efficiency and accelerating clinical trial studies. I believe that leveraging on Acceliant's knowledge and expertise will prove to be immensely beneficial for us in raising the standards of clinical trial efficiency."

Sri Manchala, CEO, Acceliant, commented, "Our integrated EDC-ePRO platform with innovative workflows and built-in mobility which allows data management from anywhere, anytime is designed to keep up with the everchangingever-changing needs of the life sciences industry. Our collaboration with Croissance Clinical Research strengthens our clientele and helps us differentiate ourselves in this highly competitive marketplace."

"Keeping up with our accelerated growth in India, we are proud to partner with Croissance Clinical Research.  We look forward to a successful long-term relationship aiding them in clinical trial management. This partnership strengthens our commitment to provide unparalleled services in the space of clinical trial management solutions," said Santhosh S. Nagaraj, Sales Head, Acceliant.

About Croissance Clinical Research

Croissance Clinical Research is a full service CRO, providing services to pharmaceutical, biotechnology and medical devices companies. At Croissance Clinical Research stalwarts of the Pharmaceutical and Clinical Research Industry have come together integrating their decades of knowledge and experiences to develop an optimized system for Clinical Research Industry. We apply our innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. Specialties include Clinical Trial Operations, Site Management, Clinical Data Management, Biostatistics, Medical Writing and Quality Assurance

About Acceliant

Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant has helped facilitate clinical data management in hundreds of trials worldwide encompassing dozens of therapeutic areas for global giants as well as emerging healthcare innovators.

Prashant Bhavaraju
CMO
info@acceliant.com
+1-408-387-5899


'/>"/>
SOURCE Trianz
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MNX nomme un nouveau membre à son conseil dadministration, la société vise à accélérer sa croissance dans la logistique pour les domaines pharmaceutique et des essais cliniques
2. BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
3. Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering
4. Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nations Deadliest Cancers
5. TauRx Expands Alzheimers Clinical Trials in the United States
6. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
7. Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
8. CMC Biologics and OncoSynergy Enter into Agreement to Develop and Manufacture Material for IND Enabling Studies and Phase I Clinical Trials
9. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
10. Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America
11. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017 Ascendis Pharma A/S (Nasdaq: ... technology to address significant unmet medical needs in rare ... conference call and webcast on Monday, April 3 during ... in Orlando, Florida , to discuss ... (TransCon Growth Hormone, TransCon PTH and TransCon CNP). ...
(Date:3/23/2017)... 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" ... MD announces that AB Laboratories Inc. ("AB Labs") has ... facility under the Access to Cannabis for Medical Purposes ... . The facility, which was licensed ... currently operating at half capacity, with full production capacity ...
(Date:3/23/2017)... 2017 The global reprocessed ... the top five players accounting for nearly 94% ... are Stryker Sustainability Solutions, Ethicon (Johnson & Johnson), ... VANGUARD AG. Despite the high level of consolidation, ... the prevalence of fierce competition among the key ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... In 2016 the World Health Organization declared the Zika ... million Zika-related cases in the Americas within the next year. Lyme disease is one ... year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... Minneapolis, MN (PRWEB) , ... March 23, 2017 , ... ... with internet and WiFi connectivity are making a huge impact on businesses and individual ... Global Institute estimates the IoT will have a value anywhere from $4 trillion to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... families and businesses of the Norwalk and Vermillion areas, celebrates the newest ... (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer recovery support ...
(Date:3/23/2017)... PA (PRWEB) , ... March 23, 2017 , ... ... Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, ... , Accredited status is granted to organizations that have excellent programs for ...
Breaking Medicine News(10 mins):